Continuing To Protect the Nanotechnology Workforce: NIOSH Nanotechnology Research Plan for 2018-2025, 1735 [2019-01039]

Download as PDF Federal Register / Vol. 84, No. 24 / Tuesday, February 5, 2019 / Notices provided by Covered Persons to customers, confidentiality issues should generally not arise. However, if the Board obtains any institution-specific information during an examination of a state member bank, such information may be protected under exemption (b)(8) of the Freedom of Information Act, which exempts from disclosure materials related to the examination of financial institutions (5 U.S.C. 552(b)(8)). Current actions: On October 17, 2018, the Board published an initial notice in the Federal Register (83 FR 52452) requesting public comment for 60 days on the extension, without revision, of the Disclosure Requirements of Subpart H of Regulation H (Consumer Protections in Sales of Insurance). The comment period for this notice expired on December 17, 2018. The Board did not receive any comments. Board of Governors of the Federal Reserve System, January 30, 2019. Michele Taylor Fennell, Assistant Secretary of the Board. [FR Doc. 2019–00998 Filed 2–4–19; 8:45 am] BILLING CODE 6210–01–P The notificants listed below have applied under the Change in Bank Control Act (12 U.S.C. 1817(j)) and § 225.41 of the Board’s Regulation Y (12 CFR 225.41) to acquire shares of a bank or bank holding company. The factors that are considered in acting on the notices are set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)). The notices are available for immediate inspection at the Federal Reserve Bank indicated. The notices also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing to the Reserve Bank indicated for that notice or to the offices of the Board of Governors. Comments must be received not later than February 19, 2019. A. Federal Reserve Bank of Kansas City (Dennis Denney, Assistant Vice President) 1 Memorial Drive, Kansas City, Missouri 64198–0001: 1. F. Walter Riebenack, Evanston, Wyoming, to retain individually, voting shares of UCSB Financial Corporation, and thereby indirectly retain shares of Uinta Bank, both of Mountain View, Wyoming, and for approval to become a member of the Riebenack/Gilbert Jkt 247001 Board of Governors of the Federal Reserve System, January 30, 2019. Yao-Chin Chao, Assistant Secretary of the Board. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2019–00920 Filed 2–4–19; 8:45 am] On April 24, 2018, NIOSH published a request for public review in the Federal Register [83 FR 17824] of the draft version of the document Continuing To Protect the Nanotechnology Workforce: NIOSH Nanotechnology Research Plan for 2018–2025. All comments received were reviewed and addressed where appropriate. John J. Howard, Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. [FR Doc. 2019–01039 Filed 2–4–19; 8:45 am] BILLING CODE 4163–19–P Centers for Disease Control and Prevention BILLING CODE P [CDC–2018–0024; Docket Number NIOSH– 302] DEPARTMENT OF HEALTH AND HUMAN SERVICES [CDC–2018–0038; Docket Number NIOSH– 312] Change in Bank Control Notices; Acquisitions of Shares of a Bank or Bank Holding Company 17:22 Feb 04, 2019 SUPPLEMENTARY INFORMATION: Centers for Disease Control and Prevention FEDERAL RESERVE SYSTEM VerDate Sep<11>2014 Control Group that owns voting shares of UCSB Financial Corporation. In addition, Keith L. Gilbert, Fort Wayne, Indiana, The Cyprian Fund, LLC of Mountain View, Wyoming, the estate of Barbara A. Gilbert, Fort Wayne, Indiana, Brian K. Gilbert and Andrea R. Gilbert, Naperville, Illinois, Fred L. Gilbert and Cynthia D. Gilbert, Singapore, James Gilbert and Christina Gilbert, Akron, Ohio, Terry Gilbert, Uniondale, Indiana, Andrea S. Worsham, Altamonte Springs, Florida, and Lindsay Worsham, Altamonte Springs, Florida, have applied for approval as members of the Riebenack/Gilbert Control Group to retain shares of UCSB Financial Corporation. 1735 Continuing To Protect the Nanotechnology Workforce: NIOSH Nanotechnology Research Plan for 2018–2025 National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of availability. AGENCY: NIOSH announces the availability of Continuing to Protect the Nanotechnology Workforce: NIOSH Nanotechnology Research Plan for 2018–2015. DATES: The final document was published on January 25, 2019 on the CDC website. ADDRESSES: The document may be obtained at the following link: https:// www.cdc.gov/niosh/docs/2019-116/. FOR FURTHER INFORMATION CONTACT: Charles L. Geraci (CGeraci@cdc.gov), National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, 1090 Tusculum Ave., MS C–14, Cincinnati, OH 45226, phone (513) 533–8339 (not a toll free number). SUMMARY: PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 Final National Occupational Research Agenda for Respiratory Health National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). AGENCY: ACTION: Notice of availability. NIOSH announces the availability of the final National Occupational Research Agenda for Respiratory Health. SUMMARY: The final document was published on January 16, 2019 on the CDC website. DATES: The document may be obtained at the following link: https:// www.cdc.gov/nora/councils/resp/ agenda.html. ADDRESSES: FOR FURTHER INFORMATION CONTACT: Emily Novicki, M.A., M.P.H, (NORACoordinator@cdc.gov), National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Mailstop E–20, 1600 Clifton Road NE, Atlanta, GA 30329, phone (404) 498–2581 (not a toll free number). On March 15, 2018, NIOSH published a request for public review in the Federal Register [83 FR 11537 and 83 FR 19768] of the draft version of the National Occupational Research Agenda for Respiratory. All comments received SUPPLEMENTARY INFORMATION: E:\FR\FM\05FEN1.SGM 05FEN1

Agencies

[Federal Register Volume 84, Number 24 (Tuesday, February 5, 2019)]
[Notices]
[Page 1735]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01039]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[CDC-2018-0038; Docket Number NIOSH-312]


Continuing To Protect the Nanotechnology Workforce: NIOSH 
Nanotechnology Research Plan for 2018-2025

AGENCY: National Institute for Occupational Safety and Health (NIOSH) 
of the Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of availability.

-----------------------------------------------------------------------

SUMMARY: NIOSH announces the availability of Continuing to Protect the 
Nanotechnology Workforce: NIOSH Nanotechnology Research Plan for 2018-
2015.

DATES: The final document was published on January 25, 2019 on the CDC 
website.

ADDRESSES: The document may be obtained at the following link: https://www.cdc.gov/niosh/docs/2019-116/.

FOR FURTHER INFORMATION CONTACT: Charles L. Geraci (CGeraci@cdc.gov), 
National Institute for Occupational Safety and Health, Centers for 
Disease Control and Prevention, 1090 Tusculum Ave., MS C-14, 
Cincinnati, OH 45226, phone (513) 533-8339 (not a toll free number).

SUPPLEMENTARY INFORMATION: On April 24, 2018, NIOSH published a request 
for public review in the Federal Register [83 FR 17824] of the draft 
version of the document Continuing To Protect the Nanotechnology 
Workforce: NIOSH Nanotechnology Research Plan for 2018-2025. All 
comments received were reviewed and addressed where appropriate.

John J. Howard,
Director, National Institute for Occupational Safety and Health, 
Centers for Disease Control and Prevention.
[FR Doc. 2019-01039 Filed 2-4-19; 8:45 am]
 BILLING CODE 4163-19-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.